Literature DB >> 27846946

Appearance of lentigines in psoriasis patients treated with apremilast.

Alicia Sfecci1, Abdallah Khemis2, Jean-Philippe Lacour1, Henri Montaudié1, Thierry Passeron3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27846946     DOI： 10.1016/j.jaad.2016.06.042

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  Off-label studies on apremilast in dermatology: a review.

Authors:  Nolan J Maloney; Jeffrey Zhao; Kyle Tegtmeyer; Ernest Y Lee; Kyle Cheng
Journal:  J Dermatolog Treat       Date:  2019-04-02       Impact factor: 3.359

2.  Is Apremilast a Safe Option in Patients with History of Melanoma? A Case Series and a Review of the Literature.

Authors:  Alessio Gambardella; Gaetano Licata; Alina De Rosa; Giulia Calabrese; Roberto Alfano; Giuseppe Argenziano
Journal:  J Clin Aesthet Dermatol       Date:  2022-02

3.  Eruptive lentiginosis in resolving psoriatic plaques.

Authors:  Robert Micieli; Afsaneh Alavi
Journal:  JAAD Case Rep       Date:  2018-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.